Current role:
As the Associate Director of Analytical Operations, Phil leads a growing Pharmaceutical Analytical Chemistry department at Almac’s Loughborough site, managing a large team that supports oral solid dose development and manufacturing. He oversees stability, batch release and in-process testing, as well as method development and validation, cleaning verification, environmental monitoring and raw materials analysis to drive efficient, GMP-aligned analytical operations.
Experience:
Phil brings over 30 years of experience in analytical chemistry and quality control, having progressed through senior roles across GMP-regulated pharmaceutical environments. His background includes serving as Analytical Group Leader and Senior Analytical Group Leader at Almac, where he supported method development, stability, release and inprocess testing for oral solid dose programmes.
He previously led analytical QC operations at Porton Biopharma (formerly Public Health England), managing testing for critical sterile injectables including Erwinase® and the UK Anthrax Vaccine, and held QC management and stability roles at SAFC, alongside earlier analytical positions with Neal’s Yard Remedies, Thermo Fisher Scientific and William Grant & Sons.
Joined Almac:
2018
